296 related articles for article (PubMed ID: 28425852)
1. Discovery of Novel 2-Amino-5-(Substituted)-1,3,4-Thiadiazole Derivatives: New Utilities for Colon Cancer Treatment.
Raj V; Rai A; Singh AK; Keshari AK; Trivedi P; Ghosh B; Kumar U; Kumar D; Saha S
Anticancer Agents Med Chem; 2018; 18(5):719-738. PubMed ID: 28425852
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound Promoted Green Synthesis, Docking Study of Indole Spliced Thiadiazole, α-amino Phosphonates as Anticancer Agents and Antityrosinase Agents.
Nikalje AG; Gawhane PA; Tiwari SV; Sangshetti JN; Damale MG
Anticancer Agents Med Chem; 2018; 18(9):1267-1280. PubMed ID: 29667556
[TBL] [Abstract][Full Text] [Related]
3. Novel 1,3,4-thiadiazoles inhibit colorectal cancer via blockade of IL-6/COX-2 mediated JAK2/STAT3 signals as evidenced through data-based mathematical modeling.
Raj V; Bhadauria AS; Singh AK; Kumar U; Rai A; Keshari AK; Kumar P; Kumar D; Maity B; Nath S; Prakash A; Ansari KM; Jat JL; Saha S
Cytokine; 2019 Jun; 118():144-159. PubMed ID: 29580751
[TBL] [Abstract][Full Text] [Related]
4. New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies.
El-Sayed NA; Nour MS; Salem MA; Arafa RK
Eur J Med Chem; 2019 Dec; 183():111693. PubMed ID: 31539778
[TBL] [Abstract][Full Text] [Related]
5. Novel dual cyclooxygenase and lipoxygenase inhibitors targeting hyaluronan-CD44v6 pathway and inducing cytotoxicity in colon cancer cells.
Misra S; Ghatak S; Patil N; Dandawate P; Ambike V; Adsule S; Unni D; Venkateswara Swamy K; Padhye S
Bioorg Med Chem; 2013 May; 21(9):2551-9. PubMed ID: 23517721
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Biological Evaluation of 1,3,5-Trisubstituted 2-Pyrazolines as Novel Cyclooxygenase-2 Inhibitors with Antiproliferative Activity.
Vahedpour T; Kaur J; Hemmati S; Hamzeh-Mivehroud M; Alizadeh AA; Wuest F; Dastmalchi S
Chem Biodivers; 2021 Mar; 18(3):e2000832. PubMed ID: 33620122
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel indanone containing spiroisoxazoline derivatives with selective COX-2 inhibition as anticancer agents.
Abolhasani H; Zarghi A; Komeili Movahhed T; Abolhasani A; Daraei B; Dastmalchi S
Bioorg Med Chem; 2021 Feb; 32():115960. PubMed ID: 33477020
[TBL] [Abstract][Full Text] [Related]
8. Application of a Validated QSTR Model for Repurposing COX-2 Inhibitor Coumarin Derivatives as Potential Antitumor Agents.
Tugcu G; Sipahi H; Aydin A
Curr Top Med Chem; 2019; 19(13):1121-1128. PubMed ID: 31210111
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of antiproliferative effect in vitro of some 2-amino-5-(2,4-dihydroxyphenyl)-1,3,4-thiadiazole derivatives.
Matysiak J
Chem Pharm Bull (Tokyo); 2006 Jul; 54(7):988-91. PubMed ID: 16819217
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Molecular Docking of Some Novel Thiazoles and Thiadiazoles Incorporating Pyranochromene Moiety as Potent Anticancer Agents.
Gomha SM; Abdelhamid AO; Kandil OM; Kandeel SM; Abdelrehem NA
Mini Rev Med Chem; 2018; 18(19):1670-1682. PubMed ID: 29692239
[TBL] [Abstract][Full Text] [Related]
11. New nimesulide derivatives with amide/sulfonamide moieties: Selective COX-2 inhibition and antitumor effects.
Güngör T; Ozleyen A; Yılmaz YB; Siyah P; Ay M; Durdağı S; Tumer TB
Eur J Med Chem; 2021 Oct; 221():113566. PubMed ID: 34077833
[TBL] [Abstract][Full Text] [Related]
12. Improving the Hsp90 Inhibitors Containing 4-(2,4-Dihydroxyphenyl)-1,2,3-thiadiazole Scaffold: Synthesis, Affinity and Effect on Cancer Cells.
Kazlauskas E; Brukstus A; Petrikas H; Petrikaite V; Cikotiene I; Matulis D
Anticancer Agents Med Chem; 2017 Nov; 17(11):1593-1603. PubMed ID: 28270068
[TBL] [Abstract][Full Text] [Related]
13. Carboranyl Analogues of Celecoxib with Potent Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines.
Buzharevski A; Paskas S; Sárosi MB; Laube M; Lönnecke P; Neumann W; Mijatovic S; Maksimovic-Ivanic D; Pietzsch J; Hey-Hawkins E
ChemMedChem; 2019 Feb; 14(3):315-321. PubMed ID: 30602073
[TBL] [Abstract][Full Text] [Related]
14. Novel Thiourea Derivatives Bearing Sulfonamide Moiety as Anticancer Agents Through COX-2 Inhibition.
Ghorab MM; El-Gaby MSA; Alsaid MS; Elshaier YAMM; Soliman AM; El-Senduny FF; Badria FA; Sherif AYA
Anticancer Agents Med Chem; 2017; 17(10):1411-1425. PubMed ID: 28356021
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis and Biological Evaluation of a Novel Series of Thiadiazole- Based Anticancer Agents as Potent Angiogenesis Inhibitors.
Altuğ-Tasa B; Kaya-Çavuşoğlu B; Koparal AT; Turan G; Koparal AS; Kaplancıklı ZA
Anticancer Agents Med Chem; 2021; 21(15):2041-2049. PubMed ID: 33390125
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and SAR Study of the Novel Thiadiazole-Imidazole Derivatives as a New Anticancer Agents.
Gomha SM; Abdel-Aziz HM; Khalil KD
Chem Pharm Bull (Tokyo); 2016; 64(9):1356-63. PubMed ID: 27581640
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Anticancer Activity of Thiadiazole Containing Thiourea, Benzothiazole and Imidazo[2,1-b][1,3,4]thiadiazole Scaffolds.
Avvaru SP; Noolvi MN; More UA; Chakraborty S; Dash A; Aminabhavi TM; Narayan KP; Sutariya V
Med Chem; 2021; 17(7):750-765. PubMed ID: 32427086
[TBL] [Abstract][Full Text] [Related]
18. Ring fusion strategy for synthesis and lead optimization of sulfur-substituted anthra[1,2-c][1,2,5]thiadiazole-6,11-dione derivatives as promising scaffold of antitumor agents.
Lee YR; Chen TC; Lee CC; Chen CL; Ahmed Ali AA; Tikhomirov A; Guh JH; Yu DS; Huang HS
Eur J Med Chem; 2015 Sep; 102():661-76. PubMed ID: 26344783
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological evaluation and molecular docking studies of 1,3,4-thiadiazole derivatives containing 1,4-benzodioxan as potential antitumor agents.
Sun J; Yang YS; Li W; Zhang YB; Wang XL; Tang JF; Zhu HL
Bioorg Med Chem Lett; 2011 Oct; 21(20):6116-21. PubMed ID: 21889345
[TBL] [Abstract][Full Text] [Related]
20. 1,3,4-Thiadiazolo (3,2-Α) Pyrimidine-6-Carbonitrile Scaffold as PARP1 Inhibitors.
Kaviarasan L; Eldhose E; Krishnamurthy PT; Rajagopal K; Mohammed M; Prudviraj P; Byran G
Anticancer Agents Med Chem; 2021; 21(15):2050-2065. PubMed ID: 33327923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
